MYGN vs NTLA
Myriad Genetics, Inc. - Common Stock · Intellia Therapeutics, Inc. - Common Stock
Relative return (rebased to 100)
Key stats
| Metric | MYGN | NTLA |
|---|---|---|
| Price | $5.82 | $11.21 |
| Market Cap | $556.68M | $1.57B |
| P/E | — | — |
| P/B | 1.83 | 2.16 |
| P/S | 0.68 | 23.21 |
| ROE | -120.4% | -56.7% |
| Net Margin | -44.4% | -609.9% |
| Gross Margin | 69.9% | — |
| Revenue Growth | -1.6% | 16.9% |
| Dividend Yield | — | — |
| EPS | -$3.83 | -$2.95 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.